NASDAQ Healthcare Medical - Devices CBLL

CeriBell, Inc.

$ 18.03 4.34 %

CeriBell, Inc. specializes in pioneering artificial intelligence (AI)-powered electroencephalography (EEG) solutions designed for the immediate diagnosis and treatment of neurological conditions directly at the patient's bedside. The company's primary offering is the Ceribell System, an innovative, on-site EEG platform engineered to fulfill crucial, previously unmet requirements for patients in urgent medical environments. Beyond the core system, CeriBell also provides single-use EEG headbands and compact, battery-powered recording devices. Originally established in 2014 as Brain Stethoscope, Inc., the company underwent a name change to CeriBell, Inc. in August 2015. Its headquarters are located in Sunnyvale, California.

CEO: Xingjuan Chao - https://ceribell.com

Summary 30-Y Financials Dividend Analyst Key metrics Ownership / Senat
Price objectif

$25 38.66 %

Recommandation

Buy

DCF

$ -46.67

Loading data...

CBLL vs S&P500

Loading data...

No data available.

Quick ratio

9.87

suggests a healthy liquidity position, showing that the company can likely meet its short-term obligations.

P/E ratio

-11.13

may indicate that the company is undervalued or has poor growth prospects.

EPS

-1.62

is the net profit of a company divided by the number of outstanding shares, indicating the profit earned per share.

ROE

-38.19 %

indicates low profitability, suggesting that the company is not using equity efficiently to generate profits.

ROIC

-39.83 %

does not generate enough return to cover its financing costs, which indicates value destruction and may pose long-term profitability issues.

WACC

8.19

is a company's average cost of capital, weighted by the proportion of debt and equity in its financing. It represents the minimum return the company must generate to satisfy its investors.

Debt-to-Equity Ratio

0.16

indicates that the company uses more equity than debt, suggesting prudent management.

Free cash flow per share

-1.32

is a measure of a company's financial flexibility that is determined by dividing free cash flow by the total number of shares outstanding.

Dividend payout ratio

0.00 %

the dividend payout ratio is the measure of dividends paid out to shareholders relative to the company's net income.

Earnings per share

Loading data...

No data available.

Financials

Piotroski score
1 indicates worrying financial health
Altman score
9.59 indicates good financial health and low risk of bankruptcy
Loading data...

No data available.

Cash / Debt

Cash Ratio
2.80 indicates that the company has sufficient cash to cover its short-term debts
Debt Ratio
0.12 indicates that the company uses little debt to finance its assets, suggesting good financial stability
Loading data...

No data available.

Free Cash Flow

Loading data...

No data available.

Earnings Per Share (annual)

Loading data...

No data available.

Sales

Loading data...

No data available.